This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v4.0.0: STU4) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Generated Narrative: MedicationAdministration cancer-related-medication-admin-doxorubicin-jenny-m
Normalization Basis Extension: Body weight characteristic (observable entity)
status: Completed
category: Outpatient
medication: 10 ML doxorubicin hydrochloride 2 MG/ML Injection
subject: Jenny M Female, DoB: 1965-01-01 ( Medical Record Number: MRN1234 (use: usual, ))
effective: 2018-04-22
Actor |
Practitioner Nancy Nurse |
reasonReference: Condition Primary malignant neoplasm of female left breast (disorder)
note: doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/us-core-practitioner-nancy-oncology-nurse @2018-04-22)
Route | Dose |
Intravenous route (qualifier value) | 105.96 mg (Details: UCUM codemg = 'mg') |